文献
J-GLOBAL ID:202002290862209354
整理番号:20A2807777
脳デリバリーのための効果的なナノキャリアとしてのラクトース付加β-シクロデキストリン
Lactose-appended β-cyclodextrin as an effective nanocarrier for brain delivery
著者 (20件):
Yokoyama Ryoma
(Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto 862-0973, Japan)
,
Taharabaru Toru
(Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto 862-0973, Japan)
,
Nishida Takumi
(Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto 862-0973, Japan)
,
Ohno Yoshitaka
(Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto 862-0973, Japan)
,
Ohno Yoshitaka
(Program for Leading Graduate Schools “HIGO (Health life science: Interdisciplinary and Glocal Oriented) Program”, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto 862-0973, Japan)
,
Maeda Yuki
(Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto 862-0973, Japan)
,
Maeda Yuki
(Program for Leading Graduate Schools “HIGO (Health life science: Interdisciplinary and Glocal Oriented) Program”, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto 862-0973, Japan)
,
Sato Masahiro
(Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto 862-0973, Japan)
,
Ishikura Kandai
(Research Institute of Nihon Shokuhin Kako Co., Ltd, 30 Tajima, Fuji, Shizuoka 417-8530, Japan)
,
Yanagihara Kazunori
(Research Institute of Nihon Shokuhin Kako Co., Ltd, 30 Tajima, Fuji, Shizuoka 417-8530, Japan)
,
Takagi Hiroki
(Research Institute of Nihon Shokuhin Kako Co., Ltd, 30 Tajima, Fuji, Shizuoka 417-8530, Japan)
,
Nakamura Teruya
(Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto 862-0973, Japan)
,
Nakamura Teruya
(Priority Organization for Innovation and Excellence, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto 862-0973, Japan)
,
Ito Shingo
(Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto 862-0973, Japan)
,
Ohtsuki Sumio
(Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto 862-0973, Japan)
,
Arima Hidetoshi
(Laboratory of Evidence-Based Pharmacotherapy, Daiichi University of Pharmacy, 22-1 Tamagawa-machi, Minami-ku, Fukuoka 815-8511, Japan)
,
Onodera Risako
(Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto 862-0973, Japan)
,
Higashi Taishi
(Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto 862-0973, Japan)
,
Higashi Taishi
(Priority Organization for Innovation and Excellence, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto 862-0973, Japan)
,
Motoyama Keiichi
(Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto 862-0973, Japan)
資料名:
Journal of Controlled Release
(Journal of Controlled Release)
巻:
328
ページ:
722-735
発行年:
2020年12月10日
JST資料番号:
C0308D
ISSN:
0168-3659
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)